1. Home
  2. ULY vs KLTO Comparison

ULY vs KLTO Comparison

Compare ULY & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • KLTO
  • Stock Information
  • Founded
  • ULY 2013
  • KLTO 2019
  • Country
  • ULY United States
  • KLTO United States
  • Employees
  • ULY N/A
  • KLTO N/A
  • Industry
  • ULY
  • KLTO
  • Sector
  • ULY
  • KLTO
  • Exchange
  • ULY Nasdaq
  • KLTO NYSE
  • Market Cap
  • ULY 6.0M
  • KLTO 5.0M
  • IPO Year
  • ULY N/A
  • KLTO N/A
  • Fundamental
  • Price
  • ULY $4.66
  • KLTO $0.16
  • Analyst Decision
  • ULY Strong Buy
  • KLTO
  • Analyst Count
  • ULY 1
  • KLTO 0
  • Target Price
  • ULY $12.00
  • KLTO N/A
  • AVG Volume (30 Days)
  • ULY 23.8K
  • KLTO 152.3K
  • Earning Date
  • ULY 05-12-2025
  • KLTO 05-15-2025
  • Dividend Yield
  • ULY N/A
  • KLTO N/A
  • EPS Growth
  • ULY N/A
  • KLTO N/A
  • EPS
  • ULY N/A
  • KLTO N/A
  • Revenue
  • ULY $142,905,000.00
  • KLTO N/A
  • Revenue This Year
  • ULY N/A
  • KLTO N/A
  • Revenue Next Year
  • ULY $17.87
  • KLTO N/A
  • P/E Ratio
  • ULY N/A
  • KLTO N/A
  • Revenue Growth
  • ULY N/A
  • KLTO N/A
  • 52 Week Low
  • ULY $2.99
  • KLTO $0.11
  • 52 Week High
  • ULY $32.04
  • KLTO $13.10
  • Technical
  • Relative Strength Index (RSI)
  • ULY 47.91
  • KLTO N/A
  • Support Level
  • ULY $4.42
  • KLTO N/A
  • Resistance Level
  • ULY $5.10
  • KLTO N/A
  • Average True Range (ATR)
  • ULY 0.38
  • KLTO 0.00
  • MACD
  • ULY 0.05
  • KLTO 0.00
  • Stochastic Oscillator
  • ULY 60.49
  • KLTO 0.00

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: